Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
- PMID: 35250889
- PMCID: PMC8889626
- DOI: 10.3389/fendo.2022.840299
Corrigendum: Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
Abstract
[This corrects the article DOI: 10.3389/fendo.2021.615409.].
Keywords: NAFLD; meta-analysis; pioglitazone; prediabetes; type 2 diabetes mellitus.
Copyright © 2022 Lian and Fu.
Figures

Erratum for
-
Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis.Front Endocrinol (Lausanne). 2021 Apr 28;12:615409. doi: 10.3389/fendo.2021.615409. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33995271 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources